Y4Q-65706-59221
2 vaccinations
2 coded responses
3 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 907 / CA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Moderna
-
2021-03-23
Dose 2 — Moderna
-
2021-03-24
Registered in v-safe
-
2021-03-24
Survey response — day 21, dose 1MedDRA: Chest pain, Decreased appetite, Dehydration, Dyspnoea, Palpitations — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Shortness of breath, racing heart, fever, loss of appetite, dehydration, chest painsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Dizziness, Palpitations — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Racing heart, lightheadedness, chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-03-24
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Moderna | |
| 2 | 2021-03-23 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-24 | priority 2/3 | |
| 2021-03-24 | priority 2/3 | |
| 2021-03-25 | priority 2/3 |
Free text
Release 6 — day 21, dose 1
Symptoms: Shortness of breath, racing heart, fever, loss of appetite, dehydration, chest pains
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Racing heart, lightheadedness, chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Dehydration | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release